Compare ISD & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ISD | ANGO |
|---|---|---|
| Founded | 2012 | 1988 |
| Country | United States | United States |
| Employees | N/A | 675 |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.5M | 462.0M |
| IPO Year | N/A | 2004 |
| Metric | ISD | ANGO |
|---|---|---|
| Price | $14.61 | $11.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 72.7K | ★ 383.3K |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | ★ 9.69% | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.11 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $11.82 | $8.27 |
| 52 Week High | $14.79 | $13.99 |
| Indicator | ISD | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 54.73 |
| Support Level | $14.47 | $10.37 |
| Resistance Level | $14.65 | $11.92 |
| Average True Range (ATR) | 0.12 | 0.43 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 20.69 | 71.11 |
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.